The incidence and outcome of myeloid malignancies in 2,112 adult patients in south East-England

Haematologica

Volumn 91, Issue 10, 2006, Pages 1400-1404

  Phekoo, Karen J ^a   Richards, Mike A ^b   Møller, Henrik ^c   Schey, Steve A ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Incidence; Myeloid malignancies; Survival

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; SURVIVAL; THROMBOCYTHEMIA; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ENGLAND; FEMALE; HUMANS; INCIDENCE; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33750020532     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jaffe ES, Harris, NL, Stein H, Vardiman JW. World Health Organisation Classification of Tumours: Tathology & Genetics: Tumours of Haematopoietic and Lymphoid Tissues, 3rd ed. Lyon: World Health Organisation. 2001.
2. Bose S, Roche M, Ross H, Watters A, Watts B. Hematological Malignancies in the Four Counties. Oxford Cancer Intelligence Unit. 2002.
3. Maynadie M, Verret C, Moskovtchenko P, Mugneret F, Petrella T, Caillot D, et al. Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population. Br J Cancer 1996;74:288-90.
4. Ridell B, Carneskog J, Wedel H, Vilen L, Hogh Dufva I, Mellqvist UH, et al. Incidence of chronic myeloproliferative disorders in the city of Goteborg, Sweden 1983-1992. Eur J Haematol 2000;65:267-71.
5. Phekoo K, Moller H, Bevan D, Bell S, Schey S. Engaging clinicians with a Cancer Registry improves ascertainment rates in haematological malignancies. American Society of Haematologists. Philadelphia. Blood; 2002 [Abstract].
6. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451-8.
7. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-99.
8. Pearson TC, Messinezy M. The diagnostic criteria of polycythaemia rubra vera. Leuk Lymphoma. 1996;22 Suppl 1:87-93.
9. Nowell PC HD. A minute chromosome in human chronic granulocytic leukemia. Science 1960:132-7.
10. Jensen OM, Parkin DM, Maclennan R, Muir CS, Skeet RG. Cancer registration principles and methods. Lyon: International Agency for Research on Cancer, Scientific Publications. 1991.
11. McNally RJ, Roman E, Cartwright RA. Age and sex distributions of hematological malignancies in the U.K. Hematol Oncol. 1997;15:173-89.
12. Germing U SC, Kundgen A, Bowen D, Aul C, Haas R, Gattermann N. No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 2004;89:905-10.
13. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, et al. Cancer Genome Project. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;365:1054-61.
14. Coleman MP, Babb P, Damiecki P, Grouslaude P, Honjo S, Jones J, et al. Cancer Survival Trends in England and Wales 1971-1995 Deprivation and NHS Region. London: Office of National Statistics. 1999.
15. Sant M, Aareleid T, Berrino F. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 2003;14 Suppl 5:v61-118.
16. Menzin J, Lang K, Earle CC, Kerney D, Mallick R. The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med 2002;162:1597-603.
17. Taylor PR. Leukaemia Survival in the Northern Registry. 2001.
18. Bowen D, Culligan D, Jowitt S, Kelsey S, Mufti G, Oscier D, et al. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. The UK MDS Guidelines Group. Br J Haematol 2003;120:187-200.
19. Onida F, Kantarjian HM, Smith TL, Ball G, Rearing MJ, Estey EH, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood 2002;99:840-9.
20. Mesa RA, Silverstein MN, Jacobsen SJ, Wollan PC, Tefferi A. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. Am J Hematol 1999;61:10-5.